Bengaluru Science & Technology cluster (BeST)

We are a growing company trying to overcome the hurdles in healthcare industry. We believe that with our expertise on IgY antibody technology, we can definitely improve the quality of life and save many more lives from diseases caused by various microbials. Our unique approach and knowledge base enable the creation of immune health solutions that address a range of needs related to the health of humans and animals. Antimicrobials   Many therapeutic approaches are available to address the pathogens which includes, probiotics, antibiotics, bacteriophages and others, but safety and antibiotic resistance is the major concern. To address these limitations, Kyntox Biotech is using avian (IgY) antibody technology that is safe and effective against specific and narrow targeted bacteria/ fungi/viruses. Being polyclonal, our technology prevents the generation of resistance to therapy, unlike any antibiotics/small molecules for long term dosing. IgY based Therapeutics: For selective removal o...

 The startup scene in India has been seeing tremendous activity in the last few years and with the emergence of Artificial intelligence , it has only lead to a faster growth in people trying to use AI in giving solutions to everyday problems. The startup scene in India has been seeing tremendous activity in the last few years and with the emergence of Artificial intelligence , it has only lead to a faster growth in people trying to use AI in giving solutions to everyday problems. StrideAIde was an offshoot of collaborative research between IISC & KIER. The scientists from IISC lead by Dr.Ananthasuresh from the mechanical engineering department and doctors from KIER lead by Dr.Belehalli Pavan from the department of Podiatry where working on giving solutions to diabetic population with diabetic foot wounds. After their first product – “Dynamic self offloading foot insoles” showed amazing field results , it was decided to take this collaboration a step further and include Artifici...

 " Can we predict diabetic foot ulcers before they happen ? Can we predict a charcot s foot ? "  These were the questions that we ( KIER-IISc research wing) have set out on. We learnt that using artificial intelligence and machine learning we can do much more than that by creating a " DIGITAL FOOT TWIN" which can undergo the same changes as that of a patient . We used this system to come up with a risk stratification system for diabetic foot   The result was D-PoC ( Digital podiatry clinic) which not only quantities the deadly complication of diabetic foot but also can be used both as a diabetic foot registry as well as a screening and alarm system for indicating the impending complications. This is the first step in the long road of reducing the amputation rates in India . Meanwhile KIER - IISc research wing keeps up to its promise of simplifying health using technology. Special thanks to dr. Anil kumar , Dr. Vishu, Dr.Prabdeep , Mr.Ravi and the BeST cluster , Dr.a...

  My name is Vivek Sharanappa and I'm the Co-founder & CEO of BUYMYEV TECHNOLOGY PVT LTD and I'm going to talk briefly about my startup/entrepreneur journey in a short write up. Each instance I devoted to waiting for the car to arrive from the metro station meant  forfeiting valuable evening playtime with my daughter, an eagerly anticipated moment.  Alternatively, it led to unpleasant discussions about the excess fares that needed to be paid.  Despite my attempt at cycling to work, as I am an enthusiastic cyclist, the endeavor  proved  ineffective due to the polluted commute. Having been raised in Bangalore, a hub  for  innovation, and working as a technology professional for renowned global brands such as  Novell and Hewlett Packard, it was disheartening to find no resolution to this issue. The  onset of COVID-19 made shared mobility appear more perilous. This marked the  commencement of my pursuit of a short-distance comm...

  We are excited to bring you the latest insights into the world of healthcare innovation with a focus on Ai Health Highway. In this edition of our newsletter, we delve into the remarkable journey of Dr. (Maj) Satish S Jeevannavar, the founder of Ai Health Highway, and explore how his visionary approach is transforming the healthcare landscape. Founder's Vision: From Medicine to MedTech  Ai Health Highway was founded in 2018 by Dr. (Maj) Satish S Jeevannavar, an accomplished physician and ex-army medical corps officer. What led him to transition into the role of CEO in a medtech startup, you may wonder? Dr. Satish's 22+ years of experience, spanning various healthcare sectors, played a pivotal role in shaping his vision. With a background that includes scaling startups in Primary Healthcare, mHealth, Pharma, and Life Science Strategy Consulting, he brought a unique perspective to the table.  Awards and Recognition Under Dr. Satish's leadership, Ai Health Highway has achie...